ask="39.50"
ask_size="100"
average_daily_volume="1396820"
bid="36.36"
bid_size="500"
book_value="11.83"
change="-0.54"
change_from_200_day_moving_average="-16.98"
change_from_50_day_moving_average="-3.48"
change_from_52_week_high="-42.49"
change_From_52_week_low="6.24"
change_in_percent="-1.42%"
close="37.62"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.82"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70877000"
high="38.87"
high_52_weeks="80.11"
last_trade_date="1/24/2017"
last_trade_price="37.62"
last_trade_size="72528"
last_trade_time="4:00pm"
low="36.65"
low_52_weeks="31.38"
market_capitalization="3.23B"
moving_average_200_day="54.60"
moving_average_50_day="41.10"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="63.36"
open="38.19"
pe_ratio="N/A"
peg_ratio="-0.18"
percent_change_from_200_day_moving_average="-31.09%"
percent_change_from_50_day_moving_average="-8.47%"
percent_change_from_52_week_high="-53.04%"
percent_change_from_52_week_low="+19.89%"
previous_close="38.16"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.22"
price_per_sales="87.90"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="5.47"
stock_exchange="NMS"
symbol="ALNY"
volume="774336"
weeks_range_52="31.38 - 80.11"
